跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Loviscol - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Loviscol
Approved
STANDARD
Loviscol
Interphil Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
022de21c31cf81b8
Company
Interphil Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
022de21c31cf81b8
Drug Approval Philippines Name
Loviscol
Product Name
Loviscol
Registration Number
DRHR-1265
Brand Name
Loviscol
Generic Name
Carbocisteine
Dosage Form
Syrup (Oral Drops)
Dosage Strength
50 mg/mL
Manufacturer
Interphil Laboratories, Inc.
Trader
GlaxoSmithKline Consumer Healthcare Philippines, Inc.
Issuance Date
26 March 2021
Expiry Date
07 March 2026
Pharmacologic Category
Mucolytic
Classification
Household Remedy (HR)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
022de21c31cf81b8
Type
Standard
Back to Philippines FDA Approvals